Printer Friendly

Browse Atopic dermatitis topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Arena Pharmaceuticals reports Q2 EPS ($1.61), consensus ($2.03). Financial report Aug 5, 2020 157
AbbVie Phase 3 upadacitinib plus TCS study met co-primary, secondary endpoints. Jul 28, 2020 290
AbbVie: RINVOQ met primary, secondary endpoints in second Phase 3 study. Jul 21, 2020 176
Tocagen, Forte Biosciences Close Merger to Accelerate Inflammatory Skin Disease Treatment. Jul 8, 2020 342
Aclaris submits IND application for topical 'soft' JAK1/3 inhibitor. Jul 7, 2020 194
California wildfires caused uptick in clinic visits for atopic dermatitis, itch. Craven, Jeff Jul 1, 2020 677
Maximizing the care of our unique patients. Baldwin, Hilary E. Jul 1, 2020 500
More phase 3 data reported on abrocitinib for atopic dermatitis. Jancin, Bruce Jul 1, 2020 573
Eosinophilic Gastritis in a Patient Previously Treated with Dupilumab. Iwamuro, Masaya; Murakami, Toshi; Tanaka, Takehiro; Oka, Shohei; Kawano, Seiji; Kawahara, Yoshiro; O Jun 30, 2020 2368
Tocagen, Forte Biosciences Close Merger to Accelerate Inflammatory Skin Disease Treatment. Jun 29, 2020 342
Webinar series launched to address allergic rhinitis. Jun 24, 2020 772
health NOTES. Jun 20, 2020 181
Sanofi granted approval for Dupixent in China. Jun 19, 2020 188
FDA approves new Depuxient pre-filled pen. Jun 19, 2020 306
FDA approves new Dupixent pre-filled pen. Jun 19, 2020 294
health NOTES. Jun 18, 2020 181
AbbVie's Rinvoq meets efficacy endpoints in Phase 3 dermatitis study. Report Jun 18, 2020 246
Cara to increase KARE Phase 2 trial size by 28% following IDMC recommendation. Jun 17, 2020 299
health NOTES. Jun 16, 2020 178
health NOTES. Jun 16, 2020 181
health NOTES. Jun 16, 2020 181
health NOTES. Jun 16, 2020 181
Tocagen, Forte Biosciences Close Merger to Accelerate Inflammatory Skin Disease Treatment. Jun 16, 2020 342
Tocagen, Forte Biosciences Close Merger to Accelerate Inflammatory Skin Disease Treatment. Jun 16, 2020 312
health NOTES. Jun 16, 2020 181
health NOTES. Jun 16, 2020 181
health NOTES. Jun 16, 2020 181
health NOTES. Jun 16, 2020 181
health NOTES. Jun 15, 2020 181
Pfizer reports 'positive' results from Phase 3 JADE TEEN study of abrocitinib. Jun 10, 2020 278
New topicals coming for pediatric atopic dermatitis. Jancin, Bruce Jun 1, 2020 785
Fast, aggressive eczema treatment linked to fewer food allergies by age 2 years. Smith, Jennie Jun 1, 2020 514
Omalizumab proves effective for treating patients with severe pediatric atopic dermatitis. Cimino, Steve Jun 1, 2020 698
Frequent soaks ease pediatric atopic dermatitis. Splete, Heidi Jun 1, 2020 559
Sensitizer prevalent in many hypoallergenic products for children. Palmer, Christopher Jun 1, 2020 299
Dermatologic treatments can be complementary. Sidbury, Robert; Eichenfield, Lawrence F. Jun 1, 2020 517
Which children are at greatest risk for AD? Jancin, Bruce Jun 1, 2020 807
Early onset of AD linked to poorer control. Nogrady, Bianca Jun 1, 2020 752
Patients with AD should routinely be asked about conjunctivitis. Craven, Jeff Jun 1, 2020 896
Patch testing in atopic dermatitis: When and how. Jancin, Bruce Jun 1, 2020 1071
Fast, aggressive eczema treatment linked to fewer food allergies by age 2 years. Smith, Jennie Jun 1, 2020 513
Omalizumab proves effective for treating patients with severe pediatric atopic dermatitis. Cimino, Steve Jun 1, 2020 697
Frequent soaks ease pediatric atopic dermatitis. Splete, Heidi Jun 1, 2020 558
Sensitizer prevalent in many hypoallergenic products for children. Palmer, Christopher Jun 1, 2020 322
More screening for depression recommended. Jancin, Bruce Jun 1, 2020 999
Multiple therapies in advanced-stage development. Jancin, Bruce Jun 1, 2020 1581
Dermatologic treatments can be complementary. Sidbury, Robert; Eichenfield, Lawrence F. Jun 1, 2020 510
Which children are at greatest risk for AD? Jancin, Bruce Jun 1, 2020 807
Early onset of AD linked to poorer control. Nogrady, Bianca Jun 1, 2020 753
Patients with AD should routinely be asked about conjunctivitis. Craven, Jeff Jun 1, 2020 896
Patch testing in atopic dermatitis: When and how. Jancin, Bruce Jun 1, 2020 1075
The Role of MIF-173G/C Gene Polymorphism in the Susceptibility of Autoimmune Diseases. Du, Xiangrong; Li, Ruixia; Song, Shoujun; Ma, Lei; Xue, Haibo May 31, 2020 10753
Antipruritic Effect of Ethyl Acetate Extract from Fructus cnidii in Mice with 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis. Chen, Xi; Zhu, Chan; Zhang, Yingge; Yang, Niuniu; Shi, Hao; Yang, Weiwei; Yang, Yan; Liang, Jianqian May 31, 2020 7446
Arena Pharmaceuticals completes enrolment of Phase 2b ADVISE trial assessing etrasimod. May 27, 2020 247
Arena Pharmaceuticals completes enrolment of Phase 2b ADVISE trial assessing etrasimod. May 27, 2020 243
Regeneron, Sanofi announce FDA approval of Dupixent for children. May 26, 2020 153
American Skin Association Awards Research Grants. May 1, 2020 444
New topicals are coming for pediatric atopic dermatitis. Jancin, Bruce May 1, 2020 756
Continuous long-term dupilumab is best strategy. Jancin, Bruce May 1, 2020 1166
Incidence of Keratoconus and Its Association with Systemic Comorbid Conditions: A Nationwide Cohort Study from South Korea. Moon, Jong Youn; Lee, Jesang; Park, Yoon Hyung; Park, Eun-Cheol; Lee, Si Hyung Report Apr 30, 2020 4045
Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey. Sastre, Joaquin; Baldrich, Esther Serra; Hita, Jose Carlos Armario; Herraez, L.; Jauregui, Ignacio; Apr 30, 2020 8855
Primary Cutaneous CD30+ Anaplastic Large T Cell Lymphoma in a Patient Treated with Cyclosporine for Actinic Reticuloid. Gambichler, T.; Patsinakidis, N.; Susok, L.; Segert, M.H.; Doerler, M. Apr 30, 2020 2608
UPDATE: Sanofi Affirms Guidance As Covid-19 Stocking Boosts Quarter. Apr 24, 2020 645
LEO Pharma, Oneness Biotech and Microbio Shanghai partnership to develop the drug candidate FB825 for atopic dermatitis and asthma. Apr 15, 2020 240
LEO Pharma, Oneness Biotech and Microbio Shanghai partnership to develop the drug candidate FB825 for atopic dermatitis and asthma. Apr 15, 2020 236
Aslan intends to resume screening after government restrictions lifted. Clinical report Apr 13, 2020 156
Regeneron, Sanofi: Dupixent shows significant improvement in atopic dermatitis. Apr 3, 2020 487
Relationship Between Atopic Dermatitis and Food Allergies. Klotter, Jule Apr 1, 2020 293
What's your diagnosis? Apr 1, 2020 195
Best Practices Colloidal Oatmeal: Optimal Skin-Directed Care for Atopic Dermatitis: A review of a Product Theater presentation by Dr. Zeichner. Zeichner, Joshua A. Apr 1, 2020 2827
A 7-month-old male presents with perioral rash and fever. Bhatti, Safiyyah; Eichenfield, Lawrence F. Apr 1, 2020 889
Colloidal Oatmeal: Optimal Skin-Directed Care for Atopic Dermatitis: A review of a Product Theater presentation by Dr. Zeichner. Zeichner, Joshua A. Apr 1, 2020 2813
Treatment may vary based on race, gender, and insurance. Splete, Heidi Clinical report Apr 1, 2020 543
Anaphylaxis risk higher in egg-, milk-allergic children. Splete, Heidi Apr 1, 2020 424
Emollients didn't prevent AD in high-risk and other infants. Kling, Jim Clinical report Apr 1, 2020 1036
What is the diagnosis? Apr 1, 2020 303
Rosmarinus officinalis L. (Rosemary) Extraeis Containing Carnosic Acid and Carnosol are Potent Quorum Sensing Inhibitors of Staphylococcus aureus Virulence. Nakagawa, Seitaro; Hillebrand, Greg G.; Nunez, Gabriel Report Apr 1, 2020 5221
Enhancement of Chemokine mRNA Expression by Toll-Like Receptor 2 Stimulation in Human Peripheral Blood Mononuclear Cells of Patients with Atopic Dermatitis. Yu, Yangyang; Lin, Dongxu; Cai, Xiaoqiong; Cui, Danni; Fang, Ran; Zhang, Wei; Yu, Bo; Wang, Xiaomei Mar 31, 2020 4113
Rapt Therapeutics reports Q4 EPS (87c), two est. (69c). Financial report Mar 30, 2020 278
Evolve BioSystems Inc partners with Janssen to study B. infantis EVC001 in reduction of childhood atopic dermatitis. Mar 27, 2020 282
Evolve BioSystems Inc partners with Janssen to study B. infantis EVC001 in reduction of childhood atopic dermatitis. Mar 27, 2020 286
Kindred Biosciences announces results from pilot study of KIND-025. Clinical report Mar 24, 2020 151
Aslan Pharmaceuticals reports Q4 EPS (7c), consensus (17c). Financial report Mar 18, 2020 173
Pfizer says Phase 3 JADE COMPARE study met co-primary efficacy endpoints. Mar 18, 2020 266
How to avoid dry skin in babies and toddlers. Dr. Amy Lynn Stockhausen American Academy of Pediatrics Mar 15, 2020 658
American Skin Association awards 13 skincare and disease research grants. Mar 13, 2020 186
American Skin Association awards 13 skincare and disease research grants. Mar 13, 2020 182
Hoth Therapeutics says operations have not been affected by COVID-19. Mar 9, 2020 156
What is the diagnosis? Mar 1, 2020 291
Effect of Hataedock Treatment on Epidermal Structure Maintenance through Intervention in the Endocannabinoid System. Kim, Hee-Yeon; Ahn, Sang-hyun; Yang, In-Jun; Park, Sun-Young; Kim, Kibong Mar 1, 2020 9656
Memory Buttons in Combination with Mobile Application-Induced Objective and Subjective Effects in Patients with Atopic Dermatitis. Joergensen, Kristina M.; Vestergaard, Christian; Joergensen, Morten S.; Eiken, Aleksander; Malmstedt Clinical report Mar 1, 2020 3413
European experts issue guidance on AD in pregnancy. Jancin, Bruce Mar 1, 2020 1206
Task force highlights important topics. Murase, Jenny Mar 1, 2020 405
Vanda Pharmaceuticals reveals results from Phase III Tradipitant clinical trial. Clinical report Feb 26, 2020 308
Vanda Pharmaceuticals reveals results from Phase III Tradipitant clinical trial. Clinical report Feb 26, 2020 312
Tocagen, Forte Biosciences Merge to Accelerate Inflammatory Skin Disease Treatment. Feb 25, 2020 386
Tocagen, Forte Biosciences Merge to Accelerate Inflammatory Skin Disease Treatment. Feb 25, 2020 350
Eli Lilly acquires Dermira. Feb 21, 2020 244
Eli Lilly acquires Dermira. Feb 21, 2020 248
Tocagen signs definitive merger agreement with Forte Biosciences. Feb 20, 2020 227
Tocagen signs definitive merger agreement with Forte Biosciences. Feb 20, 2020 231
Sindh Rangers set ups free medical camp in coastal belt of Badin. Feb 5, 2020 254
Sanofi conference spotlights type 2 inflammations. Arab News Feb 4, 2020 383
Link Between Skin and Behavior: Itchy skin may be at the root of behavior problems. Feb 1, 2020 314
HEAD AND NECK ERYTHEMA: 'Underreported' side effect seen in AD patients on dupilumab. Jancin, Bruce Feb 1, 2020 1030
Skin barrier-dysfunction mutations vary by race, disease. Bowser, Andrew D. Feb 1, 2020 540
Study flags parental factors linked to AD risk in children. Jancin, Bruce Feb 1, 2020 523
Adult AD brings increased osteoporosis risk. Jancin, Bruce Feb 1, 2020 836
Fast, aggressive treatment linked to fewer food allergies. Smith, Jennie Feb 1, 2020 272
FDA accepts for priority review DupixentA[R] (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis. Jan 28, 2020 2045
Eczema Solution: Best Ways To Alleviate Symptoms. Joshua Tresvalles Jan 27, 2020 485
Atopic Dermatitis Market Size Is Expected to Exhibit a CAGR of 8.2% By 2023 / Share Analysis, Emerging Trends, Future Growth Analysis and Global Industry Insights. Jan 21, 2020 893
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema. Jan 21, 2020 265
Lilly to Acquire Skin Disease Specialist Dermira for USD 1.1bn in Cash. Jan 16, 2020 491
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema. Jan 16, 2020 494
Turmeric For Eczema: Does It Work? Seema Prasad Jan 14, 2020 385
Eli Lilly Reports Deal To Buy Dermira For $1.1B. Tanzeel Akhtar Jan 10, 2020 296
Eczema Therapeutics Market Expected to Expand with a CAGR of More than 9% During the Forecast Period, 2020-2024. Jan 9, 2020 714
Boragen partners with Animal Health Company for discovery and development of canine atopic dermatitis treatment. Jan 8, 2020 187
LEBRIKIZUMAB RECEIVES FDA FAST TRACK DESIGNATION. Jan 1, 2020 544
Frequent soaks eased symptoms in children with moderate-severe disease. Splete, Heidi Clinical report Jan 1, 2020 304
Survey reveals differences between naturopaths, allopaths. Splete, Heidi Jan 1, 2020 396
Melatonin and Allergic Rhinitis. Cetin, Ash Cakir; Tuncok, Yesim; Ecevit, Mustafa Cenk Jan 1, 2020 5246
Oral baricitinib performs well in phase 3 study. Jancin, Bruce Jan 1, 2020 1040
Adult atopic dermatitis brings increased osteoporosis risk. Jancin, Bruce Jan 1, 2020 823
European experts address atopic dermatitis in pregnancy. Jancin, Bruce Jan 1, 2020 1205
Janssen Pharmaceutical completes acquisition of all rights to XBiotech's bermekimab. Dec 31, 2019 144
Janssen Pharmaceutical completes acquisition of all rights to XBiotech's bermekimab. Dec 31, 2019 140
Study Shows Link Between Atopic Dermatitis and Vitiligo; Subgroup analyses show significant associations between adult, childhood AD and vitiligo. Dec 31, 2019 212
Exerts discuss aspects of atopic dermatitis at WCM-Q conference. Conference news Dec 15, 2019 437
WCM-Q Conference Hears From Experts on Skin Disease. Conference news Dec 15, 2019 437
Leo Pharma achieves primary and secondary endpoints in three phase three tralokinumab studies. Dec 13, 2019 221
Leo Pharma achieves primary and secondary endpoints in three phase three tralokinumab studies. Dec 13, 2019 225
US FDA grants Dermira's lebrikizumab fast track designation. Dec 12, 2019 272
US FDA grants Dermira's lebrikizumab fast track designation. Dec 12, 2019 268
Why an autumn walk can cause pets skin problems; WITH MARTIN PATERSON OF DONALDSON'S VETS. vet 's corner Dec 5, 2019 445
The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial. Shanthi Rexaline Dec 3, 2019 1456
18 Stocks Moving in Monday's Pre-Market Session. Lisa Levin Dec 2, 2019 525
Aslan's Rally Grows After Positive Readout From Eczema Drug Study. Shanthi Rexaline Dec 2, 2019 470
No tacrolimus/cancer link in atopic dermatitis in 10-year study. Jancin, Bruce Clinical report Dec 1, 2019 633
Survey sheds light on compliance with AD medications. Sullivan, Michele G. Dec 1, 2019 525
Persistent vulvar itch: A case of pink, symmetrical bilateral plaques on the labia majora, without evidence of atrophy or scarring and with scant white vaginal discharge. Satcher, Kerrie G.; Carstens, Stephanie J.; Kaunitz, Andrew M. Dec 1, 2019 1046
Therapeutic Effects of Chinese Herbal Formula (PTQX) on NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions. Yan, Fenggen; Zhang, Jing; Li, Xiong; Mo, Xiumei; Liu, Junfeng; Ye, Siqi; Lin, Ying; Qiu, Xiaohui; L Dec 1, 2019 6810
AnaptysBio Shares Crater On Failed Eczema Study. Shanthi Rexaline Clinical report Nov 8, 2019 419
Sanofi - Sanofi: Dupixent[R] (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis - 29/10/2019. Nov 7, 2019 375
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) - Dupixent[R] (dupilumab) Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis -- 29/10/2019. Nov 6, 2019 2149
Samsung Biologics signs long term manufacturing contract with Ichnos Sciences. Nov 6, 2019 161
Samsung Biologics signs long term manufacturing contract with Ichnos Sciences. Nov 6, 2019 157
Samsung Biologics partners with Ichnos Sciences for the manufacture of ISB 830 for atopic dermatitis. Nov 5, 2019 208
Samsung Biologics partners with Ichnos Sciences for the manufacture of ISB 830 for atopic dermatitis. Nov 5, 2019 204
Samsung BioLogics to produce drugs for Ichnos Sciences. Nov 5, 2019 589
Regeneron (NASDAQ:REGN) - Dupixent[R] (Dupilumab) Now Approved In European Union For Severe Chronic Rhinosinusitis With Nasal Polyposis -- 29/10/2019. Nov 4, 2019 887
ONCE-DAILY: JAK inhibitor for atopic dermatitis effective in phase 3 study. Jancin, Bruce Report Nov 1, 2019 886
One-year adolescent data support dupilumab efficacy, safety. Nogrady, Bianca Nov 1, 2019 623
Apple cider vinegar soaks fall short in pilot study. Rans, Caleb Nov 1, 2019 474
GC/MS Analysis of Fatty Acids on Pliek U Oil and Its Pharmacological Study by Molecular Docking to Filaggrin as a Drug Candidate in Atopic Dermatitis Treatment. Earlia, Nanda; Muslem; Suhendra, Rivansyah; Amin, Mohamad; Prakoeswa, C.R.S.; Khairan; Idroes, Rinal Nov 1, 2019 4394
Assessment of the Effectiveness of Vitamin Supplement in Treating Eczema: A Systematic Review and Meta-Analysis. Zhu, Ziyu; Yang, Ziyi; Wang, Chunyi; Liu, Handeng Report Nov 1, 2019 6344
The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis. Sun, Lixiang; Liu, Wenjie; Zhang, Ling-juan Nov 1, 2019 10656
MORE TO EXPLORE. Nov 1, 2019 498
Sanofi - Sanofi: Dupixent[R] (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis - 29/10/2019. Oct 31, 2019 375
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) - Dupixent[R] (dupilumab) Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis -- 29/10/2019. Oct 30, 2019 2150
MorphoSys ends clinical development of MOR106 in atopic dermatitis. Oct 29, 2019 191
Galapagos, MorphoSys announce end of MOR106 program in atopic dermatitis. Oct 29, 2019 152
RAPT Therapeutics starts first-in-human Phase one clinical trial for RPT193. Oct 25, 2019 205
RAPT Therapeutics starts first-in-human Phase one clinical trial for RPT193. Oct 25, 2019 201
Promising therapy for common form of eczema identified in early-stage trial. Oct 24, 2019 933
38 Stocks Moving In Friday's Mid-Day Session. Lisa Levin Oct 18, 2019 985
Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis. Oct 18, 2019 482
Dermira presents primary results from phase 2b lebrikizumab study. Oct 17, 2019 639
Pierre Fabre - The Foundation for Atopic Dermatitis is growing and becoming the Eczema Foundation! - 14/10/2019. Oct 17, 2019 110
Pfizer reveals complete results from Phase three pivotal study of Abrocitinib. Oct 15, 2019 166
Pfizer reveals complete results from Phase three pivotal study of Abrocitinib. Oct 15, 2019 162
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD. Oct 13, 2019 257
Caregivers of children with eczema suffer mild anxiety, depression. ANI Oct 11, 2019 376
Dermira initiates dosing in Phase 3 lebrikizumab study. Oct 9, 2019 119
Nektar initiates two Phase 1b studies of NKTR-358. Oct 7, 2019 104
Cephalosporins remain empiric therapy for AD skin infections. Cimino, Steve Oct 1, 2019 442
Cyclosporine for severe, refractory cases in children. Brunk, Doug Oct 1, 2019 375
Increasing interest in nicotinamide-containing products. Bosworth, Ted Oct 1, 2019 511
Pfizer says second Phase 3 study of abrocitinib achieves endpoints. Sep 27, 2019 188
XBiotech to present clinical findings for bermekimab in treatment of AD. Sep 27, 2019 238
Med-aesthetic Technology Development Responds to Rise in Skin Conditions among Canadians. Sep 24, 2019 587
XBiotech announces granting of Canadian patent covering bermekimab use. Sep 20, 2019 104
Get help for chronic body rash: dermatology professor. Sep 20, 2019 908
Home Remedies for Eczema. Sep 12, 2019 823
Sanofi - Sanofi: Dupixent[R] (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis - 6/8/2019. Sep 11, 2019 408
IEC: Regularly examine patients for conjunctivitis. Craven, Jeff Sep 1, 2019 607
Correlation of Blood FoxP3+ Regulatory T Cells and Disease Activity of Atopic Dermatitis. Li, Yan; Xu, Wei; Yao, Jingyi; Cheng, Haiyan; Sun, Xiaoli; Li, Linfeng Sep 1, 2019 4758
Treatment of Atopic Dermatitis in Pediatric Patients: Nursing Implications. Kimler, Katelin A.; McDonald, Danielle; Shah, Pooja B. Sep 1, 2019 8133
More than Skin Deep. Aug 30, 2019 170
Sanofi - Sanofi: Dupixent[R] (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis - 6/8/2019. Aug 29, 2019 408
Prurigo Nodularis Associated With Mental Health Disorders; Odds increased for mental health disorders, HIV infection, systemic illnesses. Aug 23, 2019 291
Sanofi - Sanofi : Dupixent[R] (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis - 6/8/2019. Aug 23, 2019 408
How to Protect Your Baby Against Eczema. Canter, Len Report Aug 22, 2019 288
Sanofi - Sanofi : Dupixent[R] (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis - 6/8/2019. Aug 14, 2019 408
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) - Dupixent[R] (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis -- 6/8/2019. Aug 13, 2019 842
Aslan Pharmaceuticals reports Q2 EPS (5c), consensus (20c). Financial report Aug 13, 2019 125
Kiniksa announces interim results from Phase 1b KPL-716 trial. Financial report Aug 12, 2019 395
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) - Dupixent[R] (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis -- 6/8/2019. Aug 8, 2019 842
Regeneron Pharmaceuticals Inc announces EC marketing approval for Dupixent (dupilumab) for moderate-to-severe atopic dermatitis. Aug 6, 2019 352
Regeneron Pharmaceuticals Inc announces EC marketing approval for Dupixent (dupilumab) for moderate-to-severe atopic dermatitis. Aug 6, 2019 348
Sanofi Eczema Drug Approved In Europe For Use In Teenagers. Aug 6, 2019 386
Regeneron, Sanofi say Dupixent Phase 3 trial primary, secondary endpoints. Aug 6, 2019 149
Regeneron reports Q2 EPS $6.02, consensus $5.41. Financial report Aug 6, 2019 162
NICU stay found 'protective' against risk for atopic dermatitis. Brunk, Doug Aug 1, 2019 565
6-month infection risk lowest for cyclosporine, methotrexate. Craven, Jeff Aug 1, 2019 565
Atopic Dermatitis: New Research on Disease Course and Treatment. Silverberg, Jonathan I. Aug 1, 2019 1553
35 Stocks Moving In Monday's Pre-Market Session. Jul 29, 2019 1153
Sanofi reports Q2 business EPS EUR 1.31 vs. EUR 1.25 last year. Financial report Jul 29, 2019 122
Cara Therapeutics begins Phase 2 trial of Korsuva in dermatitis. Jul 11, 2019 140
XBiotech announces Seth Forman to chair second Phase 2 study of bermekimab. Clinical report Jul 11, 2019 237
Cara Therapeutics initiates Phase 2 trial of Oral KORSUVA. Jul 9, 2019 201
Pfizer Touts Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis. Jul 5, 2019 496
Inflammatory Skin Diseases Treatment Market Growth and Sales Forecast 2018- 2026. Jul 2, 2019 785
Inflammatory Skin Diseases Treatment Market Size, Status and Forecast to 2026. Jul 2, 2019 770
Regeneron & Sanofi partnership receives CHMP recommendation for approval of Dupixent for moderate-to-severe atopic dermatitis. Jul 1, 2019 282
Regeneron & Sanofi partnership receives CHMP recommendation for approval of Dupixent for moderate-to-severe atopic dermatitis. Jul 1, 2019 278
Pfizer announces top-line results from Phase 4 study of crisaborole ointment, 2%. Jul 1, 2019 136
Some 'slime'-related contact dermatitis is allergic. Palmer, Christopher Jul 1, 2019 335
Study finds link between atopic dermatitis, late-life dementia. Bosworth, Ted Clinical report Jul 1, 2019 504
A Current Practice Snapshot of Atopic Dermatitis Management: Where We Are and Where We Need to Be. Jul 1, 2019 2343
Teledermatology management of difficult-to-treat dermatoses in the Faroe Islands. Andersen, Rune Kjaersgaard; Jemec, Gregor Borut Ernst Jul 1, 2019 1882
ECONOMIC BURDEN OF ECZEMA IN A MIDDLE-INCOME COUNTRY: A PUBLIC HOSPITAL-BASED RETROSPECTIVE STUDY IN 2016-2017 IN VIETNAM. Report Jun 30, 2019 4044
QUALITY OF LIFE MEASUREMENT ALTERATION AMONG VIETNAMESE: IMPACT AND TREATMENT BENEFIT RELATED TO ECZEMA. Report Jun 30, 2019 4551
ECONOMIC BURDEN AND PRODUCTIVITY LOSS RELATED TO ECZEMA: A PREVALENCE-BASED FOLLOW-UP STUDY IN VIETNAM. Report Jun 30, 2019 3486
Study of morphological patterns and identification of contact sensitizers of hand eczema by patch test. Report Jun 30, 2019 4443
Sanofi announces CHMP recommends approval of Dupixent. Jun 28, 2019 177
Almirall exercises its option to license rights with Dermira for Lebrikizumab in Europe for atopic dermatitis. Jun 25, 2019 345
Almirall exercises option with Dermira to license rights to lebrikizumab in EU. Jun 25, 2019 266
AnaptysBio downgraded to Neutral from Outperform at Credit Suisse. Jun 21, 2019 109
Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies during. Jun 4, 2019 786
Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies during. Jun 4, 2019 772
Aslan Pharmaceuticals completes Phase 1 study for ASLAN004 in atopic dermatitis. Jun 4, 2019 263
2019 will be an exciting year for pediatric dermatology! Eichenfield, Lawrence F. Jun 1, 2019 311
AD update: New insight into pathogenesis, prevention, and treatments. Dotinga, Randy Jun 1, 2019 1350
Pediatric Dermatology Consult: Bullous impetigo. Matiz, Catalina Jun 1, 2019 1008
PATCH TESTING AND ATOPIC DERMATITIS: When and how to test your patients. Jancin, Bruce Jun 1, 2019 891
Don't discount sleep disturbance for children with AD. Splete, Heidi Clinical report Jun 1, 2019 481
Diagnosis at 1 year links with persistent food allergies. Zoler, Mitchel L. Clinical report Jun 1, 2019 628
Food allergies and atopic dermatitis: What is the evidence? Mechcatie, Elizabeth Jun 1, 2019 285
Referral not always needed for dupilumab conjunctivitis. Otto, M. Alexander Jun 1, 2019 310
Proinflammatory diet may not trigger psoriasis, PsA, or AD. Pivovarov, Jill D. Jun 1, 2019 583
2019 will be an exciting year for pediatric dermatology! Eichenfield, Lawrence F. Jun 1, 2019 311
AD update: New insight into pathogenesis, prevention, and treatments. Dotinga, Randy Jun 1, 2019 1352
Pediatric Dermatology Consult Bullous impetigo. Matiz, Catalina Jun 1, 2019 1008
The quality of life of caregivers of children with atopic dermatitis in a South African setting. Singh, B.; Thandar, Y.; Balakrishna, Y.; Mosam, A. Clinical report Jun 1, 2019 4823
Pfizer reveals positive top-line results from phase three pivotal study of abrocitinib. Clinical report May 17, 2019 230
Pfizer reveals positive top-line results from phase three pivotal study of abrocitinib. Clinical report May 17, 2019 226
Incyte price target raised to $95 from $85 at Piper Jaffray. May 15, 2019 115
Pfizer's abrocitinib achieves all endpoints in Phase 3 study for dermatitis. May 15, 2019 234
Kiniksa presents KPL-716 data at the Society for Investigative Dermatology. May 13, 2019 411
Perinatal ve Sut Cocuklugu Doneminde Alerjik Hastaliklara Egilim Yarattigi Dusunulen Olasi Risk Faktorleri/Possible Risk Factors Associated with Allergic Diseases Among Perinatal and Infancy Period. Aktas, Selma; Say, Aysu Report May 9, 2019 4837
Stop the Itch! New Allergy Busters: These treatments may succeed where others have failed. May 1, 2019 658
Acquisition of tolerance to egg and peanut in African food-allergic children with atopic dermatitis. Gray, C.L.; Levin, M.E.; du Toit, G. Report May 1, 2019 5255
THE INDIRECT COSTS OF ALLERGIC DISEASES. Strozek, Joanna; Samolinski, Boleslaw; Klak, Anna; Gawinska-Druzba, Emilia; Izdebski, Radoslaw; Krzy Report May 1, 2019 5768
Acupuncture Treatment for Symptom Management in Atopic Dermatitis: A Study Protocol for a Randomized, Participant- and Assessor-Blind, Sham-Controlled Trial. Park, Jung Gun; Park, Hi-Joon; Chae, Younbyoung; Kim, Yu-Kang; Lee, Hyangsook; Kim, Kyuseok Clinical report May 1, 2019 7680
Preliminary Comparison of the Efficacy and Safety of Needle-Embedding Therapy with Acupuncture for Atopic Dermatitis Patients. Lee, Ho-Chan; Park, Soo-Yeon Clinical report May 1, 2019 5737
The Role of the Environmental Risk Factors in the Pathogenesis and Clinical Outcome of Atopic Dermatitis. Bonamonte, Domenico; Filoni, Angela; Vestita, Michelangelo; Romita, Paolo; Foti, Caterina; Angelini, May 1, 2019 10680
SAFETY OF PIMECROLIMUS AND TACROLIMUS IN THE TOPICAL THERAPY OF ATOPIC DERMATITIS/BEZBEDNOST LOKALNE PRIMENE PIMEKROLIMUSA I TAKROLIMUSA U TERAPIJI ATOPIJSKOG DERMATITISA. Jovanovic, Marina May 1, 2019 2891
Korean Firm To Develop Stem Cell-Based Atopic Dermatitis Drug With Kangstem Biotech. Apr 29, 2019 141
Korean Firm To Develop Stem Cell-Based Atopic Dermatitis Drug With Kangstem Biotech. Apr 29, 2019 141
Sanofi reports Q1 business EPS EUR 1.42 vs. EUR 1.28. Financial report Apr 26, 2019 122
Chugai Pharmaceutical Co., Ltd. - Nemolizumab Shows Positive Results in Maruho's Phase 3 Study in Atopic Dermatitis -- 18/4/2019. Apr 24, 2019 142
Galapagos NV, MorphoSys and Novartis announce GECKO study initiation. Apr 23, 2019 137
Is eczema affecting your quality of life? Apr 22, 2019 703
This summer, know the struggles of people #LivingWithEczema. Apr 22, 2019 436
Cantor sees 'golden egg' potential in Dermira, boosts price target to $25. Apr 18, 2019 104
Global Inflammatory Skin Diseases Treatment Market Portrays High-End Demand across Major Geographies. Apr 15, 2019 790
Encore Dermatology Acquires US Distribution Rights for Sernivo, Trianex, PromiseB. Apr 4, 2019 233
Deal snapshot: ENCORE DERMATOLOGY ACQUIRES US DISTRIBUTION RIGHTS FOR SERNIVO, TRIANEX PROMISEB. Apr 4, 2019 130
Prevalence of herbal medicines in patients with chronic allergic disorders in Western Saudi Arabia. Koshak, Abdulrahman E. Survey Apr 1, 2019 4005
Don't discount sleep disturbance with atopic dermatitis. Splete, Heidi Clinical report Apr 1, 2019 534
Probiotics for the Prevention and Treatment of Pediatric Atopic Dermatitis. Brown, Donald Cover story Apr 1, 2019 1814
The Whole-Body Approach to Treating Allergies. Lee, Clement Report Apr 1, 2019 3647
Lack of omalizumab efficacy in severe atopic dermatitis with extremely elevated IgE levels: two case reports and a literature review. Necas, Miroslav; Vasku, Vladimir; Brezinova, Eva Apr 1, 2019 2277
Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses. Xian, Dehai; Song, Jing; Yang, Lingyu; Xiong, Xia; Lai, Rui; Zhong, Jianqiao Apr 1, 2019 11141
Phellodendri Cortex: A Phytochemical, Pharmacological, and Pharmacokinetic Review. Sun, Yue; Lenon, George Binh; Wei Hong Yang, Angela Report Apr 1, 2019 12994
Anti-Atopic Dermatitis Effect of Seaweed Fulvescens Extract via Inhibiting the STAT1 Pathway. Gil, Tae-Young; Kang, Yun-Mi; Eom, Ye-Jin; Hong, Chul-Hee; An, Hyo-Jin Apr 1, 2019 6292
Aslan Pharmaceuticals announces completion of first part of ASLAN004 study. Mar 29, 2019 207
Dermira price target raised to $22 from $13 at H.C. Wainwright. Mar 27, 2019 103
Durect announces patient enrollment in Phase 1b clinical trial of oral DUR-928. Mar 27, 2019 154
HitGen signs drug discovery research collaboration with Almirall. Mar 25, 2019 156
HitGen signs drug discovery research collaboration with Almirall. Mar 25, 2019 152
Durect doses first patients in Phase 2a trial of plaque psoriasis candidate. Mar 21, 2019 120
Dermira: All 3 doses of lebrikizumab met primary endpoint. Mar 18, 2019 307
Dermira shares may rally to $15 or higher on today's data, says Mizuho. Mar 18, 2019 155
Piper pokes holes in Dermira data, says buy Regeneron on selloff. Mar 18, 2019 173
The US Food and Drug Administration approves Regeneron and Sanofi's Dupixent. Mar 14, 2019 184
The US Food and Drug Administration approves Regeneron and Sanofi's Dupixent. Mar 14, 2019 180
Regeneron Pharmaceuticals Inc wins US FDA approval for Dupixent to treat moderate-to-severe atopic dermatitis. Mar 13, 2019 282
Regeneron Pharmaceuticals Inc wins US FDA approval for Dupixent to treat moderate-to-severe atopic dermatitis. Mar 13, 2019 278
Sanofi wins US FDA approval for Dupixent to treat adolescent patients with moderate-to-severe atopic dermatitis. Mar 12, 2019 289
Sanofi wins US FDA approval for Dupixent to treat adolescent patients with moderate-to-severe atopic dermatitis. Mar 12, 2019 285
Regeneron, Sanofi announce FDA approval of Dupixent for adolescent dermatitis. Mar 12, 2019 119
Korean Biotech Selects Orgenesis' Subsidiary To Manufacture Dermatitis Treatment In Europe. Mar 4, 2019 265
Korean Biotech Selects Orgenesis' Subsidiary To Manufacture Dermatitis Treatment In Europe. Mar 4, 2019 265
Veterinary Skin Care Products Market Value Chain, Dynamics and Key Players 2018 to 2028. Mar 2, 2019 1120
NASAL POLYPS: Congestion and inflammation declined with dupilumab. Zoler, Mitchel L. Mar 1, 2019 613
Probiotic, prebiotic, and postbiotic skin care. Talakoub, Lily; Wesley, Naissan O. Mar 1, 2019 879
What's the diagnosis? Mar 1, 2019 157

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters